Operating Cash Flow (Statement)

$9.91B

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$9.91Bperiod endingJun 30, 2026

ABT TTM Cash from Operations ($1.20B → $9.91B)

TTM operating cash flow (statement)

High-resolution chart · PNG

ABT operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Abbott Laboratories Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	2,947,144,000
Mar 31, 2001	2,623,219,000
Dec 31, 2000	3,099,618,000
Sep 30, 2000	2,729,681,000
Jun 30, 2000	2,972,898,000
Mar 31, 2000	2,472,098,000
Dec 31, 1999	2,937,521,000
Sep 30, 1999	2,998,063,000
Jun 30, 1999	2,647,435,000
Mar 31, 1999	2,696,906,000
Dec 31, 1998	2,732,901,000
Sep 30, 1998	2,886,669,000
Jun 30, 1998	2,962,504,000
Mar 31, 1998	2,725,524,000
Dec 31, 1997	2,628,767,000
Sep 30, 1997	2,580,729,000
Jun 30, 1997	2,566,958,000
Mar 31, 1997	2,482,522,000
Dec 31, 1996	2,382,062,000
Sep 30, 1996	2,222,726,000
Jun 30, 1996	2,109,376,000
Mar 31, 1996	2,141,418,000
Dec 31, 1995	1,965,581,000
Sep 30, 1995	2,146,093,000
Jun 30, 1995	2,227,364,000
Mar 31, 1995	2,173,621,000
Dec 31, 1994	2,212,137,000
Sep 30, 1994	2,092,552,000
Jun 30, 1994	2,064,797,000
Mar 31, 1994	1,957,754,000
Dec 31, 1993	1,846,909,000
Sep 30, 1993	1,883,200,000
Jun 30, 1993	1,578,000,000
Mar 31, 1993	1,556,500,000
Dec 31, 1992	1,388,800,000
Sep 30, 1992	1,294,600,000
Jun 30, 1992	1,435,400,000
Mar 31, 1992	1,476,100,000
Dec 31, 1991	1,453,200,000
Sep 30, 1991	1,413,900,000
Jun 30, 1991	1,366,100,000
Mar 31, 1991	1,228,800,000
Dec 31, 1990	1,200,900,000